Skip to main content
Top
Published in: Acta Epileptologica 1/2024

Open Access 01-12-2024 | Encephalopathy | Commentary

Revealing the complex role of CDKL5 in developmental epilepsy through a calcium channel related vision

Authors: Mengqi Yan, Xiongfeng Guo, Cenglin Xu

Published in: Acta Epileptologica | Issue 1/2024

Login to get access

Abstract

Developmental and epileptic encephalopathies are severe neurological conditions in clinical practice, among which loss-of-function mutations in brain-enriched serine-threonine kinase cyclin dependent kinase like-5 (CDKL5) exists as one of the most common types. It is unknown, therefore, how precisely CDKL5 mutations lead to neuronal hyper-excitation. A recent study that looked at the connection between voltage-gated calcium channel Cav2.3 and CDKL5 in an experimental context was published in Nature Communications. This study has revealed that Cav2.3, a physiological phosphorylation target of CDKL5, would show delayed inactivation and increased cholinergic stimulation in CDKL5 knock out conditions. This would in turn cause neuronal hyperexcitability and related enhanced seizure susceptibility. This work, in our opinion, provided fresh insight into the epileptic encephalopathies linked to CDKL5 and highlighted Cav2.3 as a possible target for it.
Literature
1.
go back to reference Guerrini R, Conti V, Mantegazza M, Balestrini S, Galanopoulou AS, Benfenati F. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum. Physiol Rev. 2023;103(1):433–513.CrossRefPubMed Guerrini R, Conti V, Mantegazza M, Balestrini S, Galanopoulou AS, Benfenati F. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum. Physiol Rev. 2023;103(1):433–513.CrossRefPubMed
2.
go back to reference Sun X, Wang T. Research progress on the pathogenesis of CDKL5 pathogenic variants and related encephalopathy. Eur J Pediatrics. 2023;182(7):3049–56.CrossRef Sun X, Wang T. Research progress on the pathogenesis of CDKL5 pathogenic variants and related encephalopathy. Eur J Pediatrics. 2023;182(7):3049–56.CrossRef
3.
go back to reference Hong W, Haviland I, Pestana-Knight E, Weisenberg JL, Demarest S, Marsh ED, et al. CDKL5 deficiency disorder-related epilepsy: a review of current and emerging treatment. CNS Drugs. 2022;36(6):591–604.CrossRefPubMedPubMedCentral Hong W, Haviland I, Pestana-Knight E, Weisenberg JL, Demarest S, Marsh ED, et al. CDKL5 deficiency disorder-related epilepsy: a review of current and emerging treatment. CNS Drugs. 2022;36(6):591–604.CrossRefPubMedPubMedCentral
4.
go back to reference Sampedro-Castaneda M, Baltussen LL, Lopes AT, Qiu Y, Sirvio L, Mihaylov SR, et al. Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability. Nat Commun. 2023;14(1):7830.CrossRefPubMedPubMedCentral Sampedro-Castaneda M, Baltussen LL, Lopes AT, Qiu Y, Sirvio L, Mihaylov SR, et al. Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability. Nat Commun. 2023;14(1):7830.CrossRefPubMedPubMedCentral
5.
go back to reference Buraei Z, Yang J. The ß subunit of voltage-gated Ca2 + channels. Physiol Rev. 2010;90(4):1461–506. CrossRefPubMed Buraei Z, Yang J. The ß subunit of voltage-gated Ca2 + channels. Physiol Rev. 2010;90(4):1461–506. CrossRefPubMed
6.
go back to reference Tai C, Kuzmiski JB, MacVicar BA. Muscarinic enhancement of R-type calcium currents in hippocampal CA1 pyramidal neurons. J Neurosci. 2006;26(23):6249–58.CrossRefPubMedPubMedCentral Tai C, Kuzmiski JB, MacVicar BA. Muscarinic enhancement of R-type calcium currents in hippocampal CA1 pyramidal neurons. J Neurosci. 2006;26(23):6249–58.CrossRefPubMedPubMedCentral
7.
go back to reference Terzic B, Davatolhagh MF, Ho Y, Tang S, Liu YT, Xia Z, et al. Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder-related deficits. J Clin Invest. 2021;131(20):e143655.CrossRefPubMedPubMedCentral Terzic B, Davatolhagh MF, Ho Y, Tang S, Liu YT, Xia Z, et al. Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder-related deficits. J Clin Invest. 2021;131(20):e143655.CrossRefPubMedPubMedCentral
8.
go back to reference Zhu ZA, Li YY, Xu J, Xue H, Feng X, Zhu YC, et al. CDKL5 deficiency in adult glutamatergic neurons alters synaptic activity and causes spontaneous seizures via TrkB signaling. Cell Rep. 2023;42(10):113202.CrossRefPubMed Zhu ZA, Li YY, Xu J, Xue H, Feng X, Zhu YC, et al. CDKL5 deficiency in adult glutamatergic neurons alters synaptic activity and causes spontaneous seizures via TrkB signaling. Cell Rep. 2023;42(10):113202.CrossRefPubMed
9.
go back to reference Wang Y, Chen Z. An update for epilepsy research and antiepileptic drug development: toward precise circuit therapy. Pharmacol Ther. 2019;201:77–93.CrossRefPubMed Wang Y, Chen Z. An update for epilepsy research and antiepileptic drug development: toward precise circuit therapy. Pharmacol Ther. 2019;201:77–93.CrossRefPubMed
10.
go back to reference Xu C, Gong Y, Wang Y, Chen Z. New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments. Pharmacol Ther. 2022;233:108026.CrossRefPubMed Xu C, Gong Y, Wang Y, Chen Z. New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments. Pharmacol Ther. 2022;233:108026.CrossRefPubMed
Metadata
Title
Revealing the complex role of CDKL5 in developmental epilepsy through a calcium channel related vision
Authors
Mengqi Yan
Xiongfeng Guo
Cenglin Xu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Acta Epileptologica / Issue 1/2024
Print ISSN: 2096-9384
Electronic ISSN: 2524-4434
DOI
https://doi.org/10.1186/s42494-024-00162-7

Other articles of this Issue 1/2024

Acta Epileptologica 1/2024 Go to the issue